OraSure Technologies EBITDA 2010-2025 | OSUR
OraSure Technologies ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| OraSure Technologies Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-17 |
| 2023 | $54 |
| 2022 | $-7 |
| 2021 | $1 |
| 2020 | $4 |
| 2019 | $26 |
| 2018 | $35 |
| 2017 | $46 |
| 2016 | $26 |
| 2015 | $14 |
| 2014 | $2 |
| 2013 | $-6 |
| 2012 | $-9 |
| 2011 | $-5 |
| 2010 | $0 |
| 2009 | $-6 |
| OraSure Technologies Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-16 |
| 2025-03-31 | $-15 |
| 2024-12-31 | $-10 |
| 2024-09-30 | $-3 |
| 2024-06-30 | $0 |
| 2024-03-31 | $-4 |
| 2023-12-31 | $7 |
| 2023-09-30 | $14 |
| 2023-06-30 | $4 |
| 2023-03-31 | $28 |
| 2022-12-31 | $19 |
| 2022-09-30 | $5 |
| 2022-06-30 | $-18 |
| 2022-03-31 | $-12 |
| 2021-12-31 | $-6 |
| 2021-09-30 | $-10 |
| 2021-06-30 | $4 |
| 2021-03-31 | $13 |
| 2020-12-31 | $10 |
| 2020-09-30 | $7 |
| 2020-06-30 | $-7 |
| 2020-03-31 | $-6 |
| 2019-12-31 | $6 |
| 2019-09-30 | $15 |
| 2019-06-30 | $7 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $13 |
| 2018-09-30 | $13 |
| 2018-06-30 | $7 |
| 2018-03-31 | $1 |
| 2017-12-31 | $12 |
| 2017-09-30 | $9 |
| 2017-06-30 | $8 |
| 2017-03-31 | $17 |
| 2016-12-31 | $9 |
| 2016-09-30 | $8 |
| 2016-06-30 | $6 |
| 2016-03-31 | $4 |
| 2015-12-31 | $6 |
| 2015-09-30 | $3 |
| 2015-06-30 | $4 |
| 2015-03-31 | $1 |
| 2014-12-31 | $-1 |
| 2014-09-30 | $3 |
| 2014-06-30 | $4 |
| 2014-03-31 | $-4 |
| 2013-12-31 | $8 |
| 2013-09-30 | $0 |
| 2013-06-30 | $-4 |
| 2013-03-31 | $-9 |
| 2012-12-31 | $-4 |
| 2012-09-30 | $-1 |
| 2012-06-30 | $-2 |
| 2012-03-31 | $-2 |
| 2011-12-31 | $2 |
| 2011-09-30 | $-3 |
| 2011-06-30 | $-2 |
| 2011-03-31 | $-2 |
| 2010-12-31 | $0 |
| 2010-09-30 | $1 |
| 2010-06-30 | $0 |
| 2010-03-31 | $-2 |
| 2009-12-31 | $-3 |
| 2009-09-30 | $2 |
| 2009-06-30 | $-4 |
| 2009-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.205B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.435B | 26.79 |
| Boston Scientific (BSX) | United States | $153.732B | 36.66 |
| Stryker (SYK) | United States | $149.077B | 30.35 |
| EssilorLuxottica (ESLOY) | France | $146.011B | 0.00 |
| Medtronic (MDT) | Ireland | $115.234B | 16.26 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.493B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.717B | 24.97 |
| ResMed (RMD) | United States | $41.881B | 29.95 |
| Agilent Technologies (A) | United States | $34.119B | 22.24 |
| GE HealthCare Technologies (GEHC) | United States | $33.772B | 15.87 |
| Terumo (TRUMY) | Japan | $27.820B | 32.97 |
| Koninklijke Philips (PHG) | Netherlands | $26.548B | 17.56 |
| Insulet (PODD) | United States | $23.052B | 77.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.663B | 13.15 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.153B | 0.00 |
| Baxter (BAX) | United States | $12.496B | 9.65 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.804B | 28.67 |
| Lantheus Holdings (LNTH) | United States | $3.750B | 10.14 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.442B | 24.08 |
| Perrigo (PRGO) | Ireland | $3.247B | 8.11 |
| Prestige Consumer Healthcare (PBH) | United States | $3.219B | 14.28 |
| ICU Medical (ICUI) | United States | $3.055B | 20.80 |
| Haemonetics (HAE) | United States | $2.616B | 11.68 |
| LeMaitre Vascular (LMAT) | United States | $2.158B | 46.28 |
| QuidelOrtho (QDEL) | United States | $1.816B | 11.43 |
| AtriCure (ATRC) | United States | $1.781B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.676B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.566B | 67.25 |
| Phibro Animal Health (PAHC) | United States | $1.291B | 16.50 |
| AdaptHealth (AHCO) | United States | $1.279B | 18.17 |
| Neogen (NEOG) | United States | $1.219B | 19.34 |
| Acuren (TIC) | United States | $1.209B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.176B | 2454.00 |
| Tilray Brands (TLRY) | Canada | $1.167B | 0.00 |
| Valneva SE (VALN) | France | $0.975B | 0.00 |
| InMode (INMD) | Israel | $0.896B | 8.29 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| SNDL (SNDL) | Canada | $0.552B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.534B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.501B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 16.10 |
| Evolus (EOLS) | United States | $0.461B | 0.00 |
| CeriBell (CBLL) | United States | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.414B | 3.67 |
| Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.315B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.300B | 0.00 |
| Omeros (OMER) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Brainsway (BWAY) | Israel | $0.273B | 55.65 |
| Viemed Healthcare (VMD) | United States | $0.270B | 20.44 |
| Aurora Cannabis (ACB) | Canada | $0.269B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.262B | 0.00 |
| High Tide (HITI) | Canada | $0.248B | 0.00 |
| Quanterix (QTRX) | United States | $0.234B | 0.00 |
| Cerus (CERS) | United States | $0.228B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.217B | 0.00 |
| Exagen (XGN) | United States | $0.212B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.176B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.38 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.09 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.084B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Safety Shot (SHOT) | United States | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.053B | 31.05 |
| Veru (VERU) | United States | $0.047B | 0.00 |
| Zynex (ZYXI) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.42 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.98 |
| Trinity Biotech (TRIB) | Ireland | $0.025B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |